Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder. Issue 2 (March 2020)

• Record Type: Journal Article
• Authors: Crotty, Karen; Freedman, Kenneth I.; Kampman, Kyle M.
• Is Part Of: Journal of addiction medicine. Volume 14:Issue 2(2020)
• Publication Date: 2020-03
• Subjects: addiction -- addiction medicine -- addiction treatment -- American Society of Addiction Medicine -- ASAM -- buprenorphine -- clinical practice guideline -- criminal justice -- Methadone -- Naloxone -- naltrexone -- opioid -- opioid use disorder -- opioid use disorder treatment -- opioids -- pain -- pregnancy -- substance use disorder -- withdrawal; Substance abuse -- Periodicals; Substance abuse -- Treatment -- Periodicals; Substance-Related Disorders -- Periodicals; 616.86005
• DOI: 10.1097/ADM.0000000000000635
• Languages: English
• ISSNs: 1932-0620

Abstract

Abstract : N/A: A Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder is published in the current issue of the Journal of Addiction Medicine. The focused update included a search of Medline's PubMed database from January 1, 2014 to September 27, 2018, as well as a search of the grey literature (archives of the Clinical Guideline Clearinghouse, and key agency and society websites) for new practice guidelines and relevant systematic reviews addressing the use of medications and psychosocial treatments in the treatment of opioid use disorder, including within special populations. The search identified 13 practice guidelines and 35 systematic reviews that informed the subsequent RAND/UCLA Appropriateness Method (RAM) process employed to facilitate the focused update by a National Guideline Committee of addiction experts. New and updated recommendations were included if they were considered: (a) clinically meaningful and applicable to a broad range of clinicians treating addiction involving opioid use; and (b) urgently needed to ensure the Practice Guideline reflects the current state of the science for the existing recommendations, aligns with other relevant practice guidelines, and reflects newly approved medications and formulations.